Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices

References

1. 1.↵
   1. Boschetti N.,
   2. Wyss K.,
   3. Mischler A.,
   4. Hostettler T.,
   5. Kempf C.

   Stability of minute virus of mice against temperature and sodium hydroxide. Biologicals 2003, 31 (3), 181–185.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
2. 2.↵
   1. Boschetti N.,
   2. Niederhauser I.,
   3. Kempf C.,
   4. Stühler A.,
   5. Löwer J.,
   6. Blümel J.

   Different susceptibility of B19 virus and mice minute virus to low pH treatment. Transfusion 2004, 44 (7), 1079–1086.

   OpenUrlPubMedGoogle Scholar
3. 3.↵
   1. Garnick R. L.

   Raw materials as a source of contamination in large-scale cell culture. Dev. Biol. Stand. 1998, 93, 21–29.

   OpenUrlPubMedWeb of ScienceGoogle Scholar
4. 4.↵
   1. Brown F.,
   2. Lubiniecki A. S.

   1. Lee C. K.

   Issues of Biological Assays for Viral Vaccines. In Viral Safety and Evaluation of Viral Clearance from Biopharmaceutical Products; Brown F., Lubiniecki A. S., Eds.; Karger: Basel, 1996.

   Google Scholar
5. 5.↵
   1. Willkommen H.

   Presentation at PDA/FDA Adventitious Viruses in Biologics, December, 2010. Hannelore.wilkommen{at}gmx.de.

   Google Scholar
6. 6.↵
   1. Gilbert N.

   Livestock plagues are spreading. Nature News February 11, 2011, doi:10.1038/news.2011.87.

   Google Scholar
7. 7.↵
   ILRI Clippings. Animal surveillance needed to stop bird flu and other human epidemics—World Bank. March 11, 2011 http://ilriclippings.wordpress.com/2011/03/11/animal-surveillance-needed-to-stop-bird-flu-and-other-human-epidemics-world-bank/

   Google Scholar
8. 8.↵
   Genzyme Press Release, http://www.genzyme.com/corp/media/GENZ%20PR-062509.asp

   Google Scholar
9. 9.↵
   1. Oehmig A.,
   2. Büttner M.,
   3. Weiland F.,
   4. Werz W.,
   5. Bergemann K.,
   6. Pfaff E.

   Identification of a calicivirus isolate of unknown origin. J. Gen. Virol. 2003, 84 (Pt. 10), 2837–2845.

   OpenUrlAbstract/FREE Full TextGoogle Scholar
10. 10.↵
    1. Smith A. W.,
    2. Iversen P. L.,
    3. Skilling D. E.,
    4. Stein D. A.,
    5. Bok K.,
    6. Matson D. O.

    Vesivirus viremia and seroprevalence in humans. J. Med. Virol. 2006, 78 (5), 693–701.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
11. 11.↵
    1. Blumel J.,
    2. Brorson K.

    1. Miesegaes G.,
    2. Bailey M.,
    3. Willkommen H.,
    4. Chen Q.,
    5. Rousch D.

    Viral Clearance Symposium Participants, Blumel J., Brorson K. Proceedings of the 2009 Viral Clearance Symposium. Dev. Biol. (Basel) 2010, 133, 3–101.

    OpenUrlPubMedGoogle Scholar